Focal malformations of cortical development: new vistas for molecular pathogenesis

Area of Science:

• Neuroscience
• Developmental Biology
• Genetics

Background:

• Focal malformations of cortical development (FMCD) are associated with neurological conditions such as intractable epilepsy and neurocognitive disabilities.
• Recent research links several FMCD subtypes to the hyperactivation of the mammalian target of rapamycin (mTOR) signaling pathway.
• The mTOR pathway regulates critical cellular processes including proliferation, size, motility, and stem cell phenotype, potentially explaining FMCD features like cytomegaly and disorganized lamination.

Purpose of the Study:

• To explore the molecular mechanisms underlying FMCD.
• To investigate the role of mTOR signaling hyperactivation in FMCD pathogenesis.
• To evaluate the therapeutic potential of mTOR inhibition for FMCD.

Main Methods:

• Review of existing literature on FMCD molecular mechanisms.
• Analysis of studies linking genetic mutations, somatic mutations, and viral infections to mTOR activation in FMCD.
• Examination of clinical trial data for mTOR inhibitors in FMCD treatment.

Main Results:

• FMCD pathogenesis involves diverse molecular mechanisms, including biallelic gene inactivation, somatic mutations, and viral infections, all converging on mTOR pathway activation.
• Enhanced mTOR signaling explains key FMCD characteristics, such as increased cell size (cytomegaly), abnormal cortical lamination, and aberrant stem cell marker expression.
• Pharmacological inhibition of mTOR has demonstrated success in clinical trials for specific FMCD subtypes.

Conclusions:

• Hyperactivation of the mTOR signaling cascade is a central mechanism in many FMCD subtypes.
• Targeting the mTOR pathway offers a promising therapeutic strategy for treating FMCD-associated neurological disorders.
• Further research into mTOR-directed therapies could revolutionize the management of these debilitating conditions.